Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Malignant T-cell-amplified sequence 1 | ||
Ligand | BDBM403158 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | MTT assay | ||
EC50 | 100.0±n/a nM | ||
Citation | Bannister, TD; Roush, WR; Choi, JY; Nair, R; Tsai, AS; Mishra, JK; Cleveland, JL Heterocyclic inhibitors of monocarboxylate transporter US Patent US10329303 Publication Date 6/25/2019 | ||
More Info.: | Get all data from this article, Assay Method | ||
Malignant T-cell-amplified sequence 1 | |||
Name: | Malignant T-cell-amplified sequence 1 | ||
Synonyms: | MCT-1 | MCT1 | MCTS1 | MCTS1_HUMAN | Multiple copies T-cell malignancies | ||
Type: | Enzyme Catalytic Domain | ||
Mol. Mass.: | 20563.62 | ||
Organism: | Homo sapiens (human) | ||
Description: | n/a | ||
Residue: | 181 | ||
Sequence: |
| ||
BDBM403158 | |||
n/a | |||
Name | BDBM403158 | ||
Synonyms: | US10329303, Example 17 | ||
Type | Small organic molecule | ||
Emp. Form. | C27H31FN4O3S | ||
Mol. Mass. | 510.623 | ||
SMILES | CC(C)Cn1c2sc(Cc3c(C)n[nH]c3C)c(-c3cc(C)cc(CO)c3F)c2c(=O)n(C2CC2)c1=O |(-3.39,-5.89,;-3.39,-4.35,;-4.73,-3.58,;-2.06,-3.58,;-2.06,-2.04,;-.72,-1.27,;.74,-1.75,;1.65,-.5,;3.19,-.5,;3.96,-1.84,;3.48,-3.3,;2.15,-4.07,;4.73,-4.21,;5.97,-3.3,;5.5,-1.84,;6.27,-.5,;.74,.74,;1.14,2.23,;.05,3.32,;.45,4.81,;-.64,5.89,;1.94,5.2,;3.02,4.12,;4.51,4.51,;5.6,3.42,;2.63,2.63,;3.72,1.54,;-.72,.27,;-2.06,1.04,;-2.06,2.58,;-3.39,.27,;-4.73,1.04,;-6.27,1.04,;-5.5,2.37,;-3.39,-1.27,;-4.73,-2.04,)| | ||
Structure |